Association of Fetal Growth Restriction With Neurocognitive Function After Repeated Antenatal Betamethasone Treatment vs Placebo: Secondary Analysis of the ACTORDS Randomized Clinical Trial

IMPORTANCE: Repeated doses of antenatal betamethasone are recommended for women at less than 32 weeks’ gestation with ongoing risk of preterm birth. However, concern that this therapy may be associated with adverse neurocognitive effects in children with fetal growth restriction (FGR) remains. OBJEC...

Descripción completa

Detalles Bibliográficos
Autores principales: Cartwright, Robert D., Crowther, Caroline A., Anderson, Peter J., Harding, Jane E., Doyle, Lex W., McKinlay, Christopher J. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484607/
https://www.ncbi.nlm.nih.gov/pubmed/30707225
http://dx.doi.org/10.1001/jamanetworkopen.2018.7636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484607/
https://www.ncbi.nlm.nih.gov/pubmed/30707225
http://dx.doi.org/10.1001/jamanetworkopen.2018.7636

Ejemplares similares